by Nathaniel Harding | Mar 25, 2024 | Blog
In an industry where women are still significantly underrepresented with women representing just 8.6% of all venture capitalists and 8% of firm partners across the country, and VC-backed startups founded solely by women still coming in at a paltry 2%, Women’s History...
by Nathaniel Harding | Mar 13, 2024 | Newsletters
Bottom Line Up Front (BLUF) Sponsorships and registration are now available for our upcoming Midcon VC Summit, and tickets are live for our Founder Hour. Discover the latest investments and significant advancements made by our portfolio companies, such as CorriXR,...
by Nathaniel Harding | Mar 11, 2024 | Blog
Cortado Ventures is thrilled to have recently invested in Cadenza Bio, an Oklahoma life sciences company developing novel therapeutic drugs to treat demyelinating, inflammatory, and neurodegenerative diseases, with a first indication in multiple sclerosis (MS). Read...
by Nathaniel Harding | Mar 5, 2024 | Media
At Cortado Ventures, we are proud to be recognized by Forbes for our commitment to supporting diversity in entrepreneurship. In a recent feature by Forbes contributor Soulaima Gourani, our efforts to empower minority entrepreneurs were highlighted, showcasing our...
